{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:10:33Z","timestamp":1777349433897,"version":"3.51.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108104"],"award-info":[{"award-number":["JP19fk0108104"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108164"],"award-info":[{"award-number":["JP19fk0108164"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20f0108164"],"award-info":[{"award-number":["JP20f0108164"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108104"],"award-info":[{"award-number":["JP20fk0108104"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Multisystem inflammatory syndrome in children (MIS-C) is a severe disease that is reportedly linked to coronavirus disease 2019. Affected patients present with gastrointestinal symptoms and cardiovascular dysfunction, in addition to Kawasaki disease-like features, suggesting the potential for overlapping disease mechanisms. Kawasaki disease has been reported among individuals of East Asian ethnicities, whereas there is minimal clinical literature regarding the occurrence of MIS-C among individuals of Asian ethnicities. A few reports thus far have described changes in cytokine kinetics during the course of disease in patients with MIS-C. We followed the temporal cytokine kinetics in a 9-year-old Japanese girl who exhibited a classical trajectory of MIS-C. The patient exhibited right cervical swelling and pain, abdominal pain, vomiting, and lip reddening, which developed 31 days after she was diagnosed with severe acute respiratory syndrome coronavirus-2 infection. The patient was diagnosed with Kawasaki disease on her fifth day of illness; because she fulfilled the criteria for MIS-C, she was also diagnosed with this disease on her fifth day of illness. Her fever rapidly resolved upon administration of intravenous immunoglobulin, aspirin, and prednisolone. On the patient's sixth day of illness, she developed acute myocarditis, which was treated with two diuretics and one vasodilator; the myocarditis ameliorated within a few days. Analyses of temporal kinetics for 71 serum cytokines revealed several patterns of cytokine changes that were consistent with the patient's clinical course of disease. Importantly, there was a clear distinction between cytokines that did and did not decrease rapidly following post-treatment fever resolution. These findings may be useful for the assessment of disease status and selection of therapy in patients with similar symptoms; they may also provide insights for basic and clinical research regarding MIS-C.<\/jats:p>","DOI":"10.3389\/fped.2021.702318","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:11:10Z","timestamp":1626873070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Case Report: Changes in Cytokine Kinetics During the Course of Disease in a Japanese Patient With Multisystem Inflammatory Syndrome in Children"],"prefix":"10.3389","volume":"9","author":[{"given":"Satoshi","family":"Takasago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Ishizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Miyoshi-Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikako","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shichino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2001010","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill."},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","article-title":"Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017\u20132018","volume":"225","author":"Ae","year":"2020","journal-title":"J Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr Int."},{"key":"B7","volume-title":"Multisystem Inflammatory Syndrome in Children and Adolescents With COVID-19: Scientific Brief, 15 May 2020","year":"2020"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomized, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"625456","DOI":"10.3389\/fped.2021.625456","article-title":"Kawasaki disease shock syndrome in Japan and comparison with multisystem inflammatory syndrome in children in European countries","volume":"9","author":"Suzuki","year":"2021","journal-title":"Front Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/tp-20-188","article-title":"Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies","volume":"10","author":"Tang","year":"2021","journal-title":"Transl Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s12098-020-03357-1","article-title":"Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic","volume":"87","author":"Rauf","year":"2020","journal-title":"Indian J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3201\/eid2704.210026","article-title":"Surveillance of COVID-19\u2013associated multisystem inflammatory syndrome in children, South Korea","volume":"27","author":"Choe","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"594127","DOI":"10.3389\/fped.2020.594127","article-title":"Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 infection in Switzerland","volume":"8","author":"Fouriki","year":"2021","journal-title":"Front Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1172\/JCI141113","article-title":"Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3345\/cep.2020.01900","article-title":"Clinical features, diagnosis and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019","volume":"64","year":"2021","journal-title":"Clin Exp Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"576912","DOI":"10.3389\/fped.2020.576912","article-title":"Hyper inflammation in two severe acute respiratory syndrome coronavirus 2-infected adolescents successfully treated with the interleukin-1 inhibitor anakinra and glucocorticoids","volume":"8","author":"Cal\u00f2 Carducci","year":"2020","journal-title":"Front Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.31138\/mjr.31.3.268","article-title":"Kawasaki disease and COVID19","volume":"31","author":"Gkoutzourelas","year":"2020","journal-title":"Mediterr J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e144554","DOI":"10.1172\/JCI144554","article-title":"Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease","volume":"131","author":"Esteve-Sole","year":"2021","journal-title":"J Clin Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"654587","DOI":"10.3389\/fimmu.2021.654587","article-title":"Plasmacytoid dendritic cells depletion and elevation of IFN-g dependent chemokines CXCL9 and CXCL10 in children with multisystem inflammatory syndrome","volume":"12","author":"Caldarale","year":"2021","journal-title":"Front immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms","volume":"40","author":"Onouchi","year":"2008","journal-title":"Nat Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fphar.2017.00163","article-title":"IL-1 inhibition may have an important role in treating refractory Kawasaki disease","volume":"8","author":"Dusser","year":"2017","journal-title":"Front Pharmacol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.702318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:11:16Z","timestamp":1626873076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.702318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":24,"alternative-id":["10.3389\/fped.2021.702318"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.702318","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"702318"}}